Diclofenac sodium patch: Completed Phase III enrollment

Cerimon completed enrollment of 208 patients in a double-blind, placebo-controlled Phase III trial evaluating its once-daily diclofenac sodium patch. Cerimon has U.S. and European rights to topical fo...